About Papyrus Therapeutics
Papyrus Therapeutics is a company based in West Chester (United States) founded in 2016 by Hani Gabra and Paul Blake. It operates as a B2B. Papyrus Therapeutics offers products and services including Extracellular Tumor Suppressor Therapies. Papyrus Therapeutics operates in a competitive market with competitors including ChemoTech, Nativis, IGEA and RanD, among others.
- Headquarter West Chester, United States
- Founders Hani Gabra, Paul Blake
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Papyrus Therapeutics
Papyrus Therapeutics offers a comprehensive portfolio of products and services, including Extracellular Tumor Suppressor Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapies aimed at suppressing tumors in multiple cancers through research.
Funding Insights of Papyrus Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Papyrus Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Papyrus Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Papyrus Therapeutics Comparisons
Competitors of Papyrus Therapeutics
Papyrus Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChemoTech, Nativis, IGEA and RanD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of electroporation devices for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Developer of a therapeutic device for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Orthopedic medical devices to promote reparative osteogenesis and joint protection
|
|
| domain | founded_year | HQ Location |
Medical devices for surgical oncology are developed using extracorporeal technologies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Papyrus Therapeutics
Frequently Asked Questions about Papyrus Therapeutics
When was Papyrus Therapeutics founded?
Papyrus Therapeutics was founded in 2016.
Where is Papyrus Therapeutics located?
Papyrus Therapeutics is headquartered in West Chester, United States. It is registered at West Chester, Pennsylvania, United States.
Who is the current CEO of Papyrus Therapeutics?
Paul Blake is the current CEO of Papyrus Therapeutics. They have also founded this company.
What does Papyrus Therapeutics do?
Papyrus Therapeutics specializes in creating extracellular tumor suppressor therapies to treat multiple types of cancers, focusing on innovative scientific research and development. The company operates from West Chester, PA, in North America, and London, UK, in Europe, engaging in oncology advancements. They aim to contribute to medical treatments by addressing tumor suppression, though specific clients or partnerships are not detailed.
Who are the top competitors of Papyrus Therapeutics?
What products or services does Papyrus Therapeutics offer?
Papyrus Therapeutics offers Extracellular Tumor Suppressor Therapies.